1. Home
  2. FOLD vs CMPO Comparison

FOLD vs CMPO Comparison

Compare FOLD & CMPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$9.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo CompoSecure Inc.

CMPO

CompoSecure Inc.

HOLD

Current Price

$20.39

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
CMPO
Founded
2002
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FOLD
CMPO
Price
$9.92
$20.39
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$30.29
$25.50
AVG Volume (30 Days)
4.6M
938.8K
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$598,704,000.00
$160,683,000.00
Revenue This Year
$21.12
$12.53
Revenue Next Year
$21.23
$9.95
P/E Ratio
N/A
N/A
Revenue Growth
21.28
N/A
52 Week Low
$5.51
$9.24
52 Week High
$10.57
$26.78

Technical Indicators

Market Signals
Indicator
FOLD
CMPO
Relative Strength Index (RSI) 64.67 54.82
Support Level $9.56 $19.26
Resistance Level $10.05 $20.30
Average True Range (ATR) 0.37 0.87
MACD -0.02 0.09
Stochastic Oscillator 51.14 89.48

Price Performance

Historical Comparison
FOLD
CMPO

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About CMPO CompoSecure Inc.

CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.

Share on Social Networks: